Literature DB >> 481462

Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

E L Bravo, R C Tarazi, R W Gifford, B H Stewart.   

Abstract

Three biochemical tests for the diagnosis of pheochromocytoma were evaluated in 24 patients with proved tumors and 40 patients whose clinical picture was suspect but who had no evidence of the disease. Measurement of resting, supine plasma catecholamines (by radioenzymatic assay) was more useful than either 24-hour urinary vanillylmandelic acid (VMA) or metanephrines or both. In only one of 23 patients with pheochromocytoma were plasma catecholamines within the range of those in patients without pheochromocytoma, as compared with urinary VMA in 11 of 22, urinary metanephrines in five of 22 and both metabolites in three of 22. These studies reaffirm the value of plasma catecholamines in the diagnosis of pheochromocytoma and indicate that urinary catecholamine metabolites are less useful. The poor correlation between the height of arterial pressure and circulating levels of catecholamines suggests that the regulation of arterial pressure in pheochromocytoma is complex.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 481462     DOI: 10.1056/NEJM197909273011302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  55 in total

1.  Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy.

Authors:  H Namba; H Kondo; S Yamashita; H Kimura; N Yokoyama; M Tsuruta; A Sato; M Izumi; H Kinoshita; S Hakariya
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

2.  Detecting pheochromocytoma: defining the most sensitive test.

Authors:  Ulrich Guller; Joe Turek; Steve Eubanks; Elizabeth R Delong; Daniel Oertli; Jerome M Feldman
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Plasma gut hormone levels in 37 patients with pheochromocytomas.

Authors:  A I Vinik; B Shapiro; N W Thompson
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 4.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

Review 5.  Anaesthesia for phaeochromocytoma.

Authors:  J Pullerits; S Ein; J W Balfe
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

Review 6.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

7.  Blood glucose control by an artificial endocrine pancreas in a patient with phaeochromocytoma.

Authors:  M Hamaji; M Miyata; R Kawamori; M Shichiri; T Mashimo; K Nakao; Y Kawashima
Journal:  Can Anaesth Soc J       Date:  1985-09

8.  Changes of circadian blood pressure patterns and cardiovascular parameters indicate lateralization of sympathetic activation following hemispheric brain infarction.

Authors:  D Sander; J Klingelhöfer
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

9.  Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Authors:  P deS Senanayake; J Denker; E L Bravo; R M Graham
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

Authors:  S K Mujais; F M Fouad; S C Textor; R C Tarazi; E L Bravo; N Hart; R W Gifford
Journal:  Br Heart J       Date:  1984-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.